Evidence map›Paper›PMID 42241229›Full record

ArticleBioinformatics (Oxford, England)2026

EPIC: multi-objective guided diffusion for epitope design in TCR-pMHC complexes.

Yueshan Huang, Gufeng Yu, Letian Chen, Haoyang Luan, Yang Yang

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yueshan HuangAGI Institute, School of Computer Science, Shanghai Jiao Tong University, Shanghai 200240, China.ORCID 0009-0002-3688-0970
Gufeng YuAGI Institute, School of Computer Science, Shanghai Jiao Tong University, Shanghai 200240, China.ORCID 0000-0003-0628-8714
Letian ChenAGI Institute, School of Computer Science, Shanghai Jiao Tong University, Shanghai 200240, China.
Haoyang LuanAGI Institute, School of Computer Science, Shanghai Jiao Tong University, Shanghai 200240, China.
Yang YangAGI Institute, School of Computer Science, Shanghai Jiao Tong University, Shanghai 200240, China.ORCID 0000-0001-5720-773X

Funding

National Natural Science Foundation of China 62272300
6 · The paper itself

Abstract

motivationT cell receptor (TCR) recognition of peptide-major histocompatibility complex (pMHC) complexes is central to adaptive immunity, yet rational design of immunogenic epitopes remains elusive due to complex triplet binding constraints and data scarcity. No existing method can generate epitopes satisfying simultaneous requirements for antigenicity, MHC presentation, and TCR specificity.

resultsWe present EPIC, a multi-objective diffusion framework that decomposes TCR-pMHC binding into three biologically grounded sub-tasks, enabling training-free gradient guidance without end-to-end retraining. By integrating ESM-based classifiers with a peptide diffusion generator, EPIC leverages heterogeneous immunological interaction datasets to generate diverse, context-aware epitopes. EPIC-designed top-three epitopes achieve lower predicted interface energies compared to ground-truth epitopes in 78.31% of test cases, while maintaining 80.1% sequence novelty and comparable structural confidence. Generated epitopes exhibit 100% uniqueness, high diversity (64.05%), and high antigenicity scores (0.4723). To our knowledge, EPIC is the first computational framework capable of de novo epitope design while explicitly integrating the triplet constraints of TCR-pMHC binding. This paradigm shift from discovery to design unlocks new potential for personalized cancer vaccines, precision adoptive T cell therapy, and rapid response to emerging infectious diseases. AVAILABILITY AND IMPLEMENTATION: The source code of EPIC is available at https://github.com/Octopus125/EPIC and archived on Zenodo (DOI: 10.5281/zenodo.18537646).

Indexed as

Computational BiologyEpitopesMajor Histocompatibility ComplexPeptidesReceptors, Antigen, T-CellSoftwareHumansImmunoinformaticsEpitopesPeptidesReceptors, Antigen, T-Cell

Identifiers

PMID42241229
PMCPMC13282085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.